Clinical Trials Directory

Trials / Completed

CompletedNCT04869670

A Study to Evaluate Safety and Effectiveness of G-POEM for Gastroparesis

A Pilot and Feasibility Trial of G-POEM for Gastroparesis to Assess Safety, Physiological Mechanisms and Efficacy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
2 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research is to evaluate the 12-month treatment effect of peroral endoscopic pyloromyotomy (G-POEM) vs. sham surgery in patients with gastroparesis that is not helped by medications and to analyze factors that may predict the outcome of the surgery.

Conditions

Interventions

TypeNameDescription
PROCEDUREGastric peroral endoscopic myotomy.Under propofol anesthesia, EndoFLIP will be used to assess pyloric diameter and distensibility, prior to and after G-POEM, performed by an endoscopist skilled in this technique. After the procedure, the patient will be observed in the hospital for 2 days. Patients will undergo an upper GI series the next day to rule out perforation. If the patient develops a complication from the procedure, he or she will be managed per standard clinical practice by the treating (unblinded) endoscopist.
PROCEDURESham Gastric peroral endoscopic myotomy.Patients assigned to the sham procedure will be treated identically as above, except for the performance of the G-POEM. Endoscopy and EndoFLIP will be performed and sedation will be stopped when the upper endoscopy is completed. Since sham endoscopy is expected to take less time than G-POEM, the patient should remain in the endoscopy procedure room for a minimum of 30 minutes (including the time required to complete the upper endoscopy). After the procedure, the patient will be observed in the hospital for 2 days. All patients will undergo an upper GI series radiographic examination the next day to rule out perforation in order to maintain study blind.

Timeline

Start date
2023-07-12
Primary completion
2025-03-03
Completion
2025-03-03
First posted
2021-05-03
Last updated
2025-03-05

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04869670. Inclusion in this directory is not an endorsement.